Literature DB >> 17942597

p21 Inhibits Cdk1 in the absence of Cdk2 to maintain the G1/S phase DNA damage checkpoint.

Ande Satyanarayana1, Mary Beth Hilton, Philipp Kaldis.   

Abstract

Cdk1 was proposed to compensate for the loss of Cdk2. Here we present evidence that this is possible due to premature translocation of Cdk1 from the cytoplasm to the nucleus in the absence of Cdk2. We also investigated the consequence of loss of Cdk2 on the maintenance of the G1/S DNA damage checkpoint. Cdk2(-/-) mouse embryonic fibroblasts in vitro as well as regenerating liver cells after partial hepatectomy (PH) in Cdk2(-/-) mice, arrest promptly at the G1/S checkpoint in response to gamma-irradiation due to activation of p53 and p21 inhibiting Cdk1. Furthermore re-entry into S phase after irradiation was delayed in Cdk2(-/-) cells due to prolonged and impaired DNA repair activity. In addition, Cdk2(-/-) mice were more sensitive to lethal irradiation compared to wild-type and displayed delayed resumption of DNA replication in regenerating liver cells. Our results suggest that the G1/S DNA damage checkpoint is intact in the absence of Cdk2, but Cdk2 is important for proper repair of the damaged DNA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17942597      PMCID: PMC2174178          DOI: 10.1091/mbc.e07-06-0525

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  66 in total

1.  Cdc2-cyclin E complexes regulate the G1/S phase transition.

Authors:  Eiman Aleem; Hiroaki Kiyokawa; Philipp Kaldis
Journal:  Nat Cell Biol       Date:  2005-07-10       Impact factor: 28.824

2.  Mitotic forces control a cell-cycle checkpoint.

Authors:  X Li; R B Nicklas
Journal:  Nature       Date:  1995-02-16       Impact factor: 49.962

Review 3.  Cell cycle checkpoints.

Authors:  A Murray
Journal:  Curr Opin Cell Biol       Date:  1994-12       Impact factor: 8.382

4.  A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay.

Authors:  S A Ahmed; R M Gogal; J E Walsh
Journal:  J Immunol Methods       Date:  1994-04-15       Impact factor: 2.303

5.  Modifications of alkaline microgel electrophoresis for sensitive detection of DNA damage.

Authors:  N P Singh; R E Stephens; E L Schneider
Journal:  Int J Radiat Biol       Date:  1994-07       Impact factor: 2.694

6.  Combined loss of Cdk2 and Cdk4 results in embryonic lethality and Rb hypophosphorylation.

Authors:  Cyril Berthet; Kimberly D Klarmann; Mary Beth Hilton; Hyung Chan Suh; Jonathan R Keller; Hiroaki Kiyokawa; Philipp Kaldis
Journal:  Dev Cell       Date:  2006-05       Impact factor: 12.270

7.  Characterization of the in vitro reconstituted cyclin A or B1-dependent cdk2 and cdc2 kinase activities.

Authors:  Z Q Pan; A Amin; J Hurwitz
Journal:  J Biol Chem       Date:  1993-09-25       Impact factor: 5.157

8.  Elimination of cdc2 phosphorylation sites in the cdc25 phosphatase blocks initiation of M-phase.

Authors:  T Izumi; J L Maller
Journal:  Mol Biol Cell       Date:  1993-12       Impact factor: 4.138

9.  Cytoplasmic accumulation of cyclin B1 in human cells: association with a detergent-resistant compartment and with the centrosome.

Authors:  E Bailly; J Pines; T Hunter; M Bornens
Journal:  J Cell Sci       Date:  1992-03       Impact factor: 5.285

10.  p34cdc2 is located in both nucleus and cytoplasm; part is centrosomally associated at G2/M and enters vesicles at anaphase.

Authors:  E Bailly; M Dorée; P Nurse; M Bornens
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

View more
  66 in total

1.  Cdk2 suppresses cellular senescence induced by the c-myc oncogene.

Authors:  Stefano Campaner; Mirko Doni; Per Hydbring; Alessandro Verrecchia; Lucia Bianchi; Domenico Sardella; Thomas Schleker; Daniele Perna; Susanna Tronnersjö; Matilde Murga; Oscar Fernandez-Capetillo; Mariano Barbacid; Lars-Gunnar Larsson; Bruno Amati
Journal:  Nat Cell Biol       Date:  2009-12-13       Impact factor: 28.824

2.  Expression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations.

Authors:  Suhwan Chang; Kajal Biswas; Betty K Martin; Stacey Stauffer; Shyam K Sharan
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

3.  Loss of Cdk2 and cyclin A2 impairs cell proliferation and tumorigenesis.

Authors:  Lakshmi Gopinathan; Shawn Lu Wen Tan; V C Padmakumar; Vincenzo Coppola; Lino Tessarollo; Philipp Kaldis
Journal:  Cancer Res       Date:  2014-05-06       Impact factor: 12.701

4.  Cdk2 is required for p53-independent G2/M checkpoint control.

Authors:  Jon H Chung; Fred Bunz
Journal:  PLoS Genet       Date:  2010-02-26       Impact factor: 5.917

5.  Overall Cdk activity modulates the DNA damage response in mammalian cells.

Authors:  Antonio Cerqueira; David Santamaría; Bárbara Martínez-Pastor; Miriam Cuadrado; Oscar Fernández-Capetillo; Mariano Barbacid
Journal:  J Cell Biol       Date:  2009-12-14       Impact factor: 10.539

6.  Cdk2 and Cdk4 regulate the centrosome cycle and are critical mediators of centrosome amplification in p53-null cells.

Authors:  Arsene M Adon; Xiangbin Zeng; Mary K Harrison; Stacy Sannem; Hiroaki Kiyokawa; Philipp Kaldis; Harold I Saavedra
Journal:  Mol Cell Biol       Date:  2009-11-23       Impact factor: 4.272

7.  PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma.

Authors:  Dima Ghannam-Shahbari; Eyal Jacob; Reli Rachel Kakun; Tanya Wasserman; Lina Korsensky; Ofir Sternfeld; Juliana Kagan; Debora Rosa Bublik; Sarit Aviel-Ronen; Keren Levanon; Edmond Sabo; Sarit Larisch; Moshe Oren; Dov Hershkovitz; Ruth Perets
Journal:  Oncogene       Date:  2018-01-30       Impact factor: 9.867

8.  A dual role of Cdk2 in DNA damage response.

Authors:  Ande Satyanarayana; Philipp Kaldis
Journal:  Cell Div       Date:  2009-05-18       Impact factor: 5.130

9.  Microglia are mediators of Borrelia burgdorferi-induced apoptosis in SH-SY5Y neuronal cells.

Authors:  Tereance A Myers; Deepak Kaushal; Mario T Philipp
Journal:  PLoS Pathog       Date:  2009-11-13       Impact factor: 6.823

10.  Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells.

Authors:  N Johnson; J Bentley; L-Z Wang; D R Newell; C N Robson; G I Shapiro; N J Curtin
Journal:  Br J Cancer       Date:  2009-12-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.